Skip to main content
Erschienen in: Heart and Vessels 9/2019

22.03.2019 | Original Article

Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis

verfasst von: Toshiki Kuno, Keita Hirano, Takayuki Abe, Shohei Imaeda, Kenji Hashimoto, Toshinobu Ryuzaki, Souichi Yokokura, Tetsuya Saito, Hiroyuki Yamazaki, Ryota Tabei, Masaki Kodaira, Yohei Numasawa

Erschienen in: Heart and Vessels | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Periprocedural bleeding is associated with an increased risk of mortality during percutaneous coronary intervention (PCI), especially in patients with severe chronic renal insufficiency. Therefore, trans-radial intervention (TRI) should be considered in these patients; however, PCI operators usually avoid this approach because of the risk of radial artery occlusion. We aimed to investigate the associations of TRI and in-hospital complications in these patients. This study included 306 consecutive patients with severe chronic renal insufficiency and/or on dialysis who underwent PCI. Patients were prospectively enrolled and divided according to the access site into TRI group and trans-femoral intervention group. Severe renal insufficiency was defined as estimated glomerular filtration rate < 30 mL/min/1.73 m2. Radial access was limited to the opposite side of the arteriovenous fistula in patients on hemodialysis. The primary study endpoint was the composite of in-hospital bleeding complications and death. TRI benefit was evaluated by inverse probability treatment weighted analysis. TRI was performed in 112 (37.3%) patients. TRI group included older patients with significantly lower rates of diabetes mellitus, dialysis, and three-vessel disease. Crossover to the other approach occurred only in TRI group (2.6%). The primary endpoint was significantly lower in TRI group (11.5% vs. 2.6%, P = 0.006). After an inverse probability treatment weighted analysis, TRI was an independent prognostic factor for a decrease in the primary endpoint (OR 0.19; 95% CI 0.051–0.73; P = 0.015). Radial artery occlusion occurred in three patients on dialysis (9.1%). TRI may determine better in-hospital outcomes in patients with severe chronic renal insufficiency and/or on dialysis.
Literatur
1.
2.
Zurück zum Zitat Kwok CS, Khan MA, Rao SV, Kinnaird T, Sperrin M, Buchan I, de Belder MA, Ludman PF, Nolan J, Loke YK, Mamas MA (2015) Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Interv 8:e001645CrossRefPubMed Kwok CS, Khan MA, Rao SV, Kinnaird T, Sperrin M, Buchan I, de Belder MA, Ludman PF, Nolan J, Loke YK, Mamas MA (2015) Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis. Circ Cardiovasc Interv 8:e001645CrossRefPubMed
3.
Zurück zum Zitat Karrowni W, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz PA (2013) Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv 6:814–823CrossRefPubMed Karrowni W, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz PA (2013) Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv 6:814–823CrossRefPubMed
4.
Zurück zum Zitat Gupta T, Paul N, Kolte D, Harikrishnan P, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Ahmed A, Cooper HA, Frishman WH, Bhatt DL, Fonarow GC, Panza JA (2015) Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. J Am Heart Assoc 4:e002069PubMedPubMedCentral Gupta T, Paul N, Kolte D, Harikrishnan P, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Ahmed A, Cooper HA, Frishman WH, Bhatt DL, Fonarow GC, Panza JA (2015) Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. J Am Heart Assoc 4:e002069PubMedPubMedCentral
5.
Zurück zum Zitat Pancholy MS, Skelding K, Scott T, Blankenship J, Pancholy SB (2017) Effect of access site choice on acute kidney injury after percutaneous coronary intervention. Am J Cardiol 120:2141–2145CrossRefPubMed Pancholy MS, Skelding K, Scott T, Blankenship J, Pancholy SB (2017) Effect of access site choice on acute kidney injury after percutaneous coronary intervention. Am J Cardiol 120:2141–2145CrossRefPubMed
6.
Zurück zum Zitat Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Piemonte TC, Pomerantsev E, Ho KK, Robbins SL, Waldman HM, Yeh RW (2013) Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc 2:e000174CrossRefPubMedPubMedCentral Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Piemonte TC, Pomerantsev E, Ho KK, Robbins SL, Waldman HM, Yeh RW (2013) Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc 2:e000174CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Numasawa Y, Inohara T, Ishii H, Yamaji K, Hirano K, Kohsaka S, Sawano M, Kuno T, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M, Investigators JPR (2018) An overview of percutaneous coronary intervention in dialysis patients: insights from a Japanese nationwide registry. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.27986 CrossRefPubMed Numasawa Y, Inohara T, Ishii H, Yamaji K, Hirano K, Kohsaka S, Sawano M, Kuno T, Kodaira M, Uemura S, Kadota K, Amano T, Nakamura M, Investigators JPR (2018) An overview of percutaneous coronary intervention in dialysis patients: insights from a Japanese nationwide registry. Catheter Cardiovasc Interv. https://​doi.​org/​10.​1002/​ccd.​27986 CrossRefPubMed
8.
Zurück zum Zitat Brancati MF, Burzotta F, Coluccia V, Trani C (2012) The occurrence of radial artery occlusion following catheterization. Expert Rev Cardiovasc Ther 10:1287–1295CrossRefPubMed Brancati MF, Burzotta F, Coluccia V, Trani C (2012) The occurrence of radial artery occlusion following catheterization. Expert Rev Cardiovasc Ther 10:1287–1295CrossRefPubMed
9.
Zurück zum Zitat Dharma S, Kedev S, Patel T, Kiemeneij F, Gilchrist IC (2015) A novel approach to reduce radial artery occlusion after transradial catheterization: postprocedural/prehemostasis intra-arterial nitroglycerin. Catheter Cardiovasc Interv 85:818–825CrossRefPubMed Dharma S, Kedev S, Patel T, Kiemeneij F, Gilchrist IC (2015) A novel approach to reduce radial artery occlusion after transradial catheterization: postprocedural/prehemostasis intra-arterial nitroglycerin. Catheter Cardiovasc Interv 85:818–825CrossRefPubMed
10.
Zurück zum Zitat Al-Jaishi AA, Oliver MJ, Thomas SM, Lok CE, Zhang JC, Garg AX, Kosa SD, Quinn RR, Moist LM (2014) Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 63:464–478CrossRefPubMed Al-Jaishi AA, Oliver MJ, Thomas SM, Lok CE, Zhang JC, Garg AX, Kosa SD, Quinn RR, Moist LM (2014) Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 63:464–478CrossRefPubMed
11.
Zurück zum Zitat Pancholy SB, Patel TM (2012) Effect of duration of hemostatic compression on radial artery occlusion after transradial access. Catheter Cardiovasc Interv 79:78–81CrossRefPubMed Pancholy SB, Patel TM (2012) Effect of duration of hemostatic compression on radial artery occlusion after transradial access. Catheter Cardiovasc Interv 79:78–81CrossRefPubMed
12.
Zurück zum Zitat Pancholy SB, Bernat I, Bertrand OF, Patel TM (2016) Prevention of radial artery occlusion after transradial catheterization: the PROPHET-II randomized trial. JACC Cardiovasc Interv 9:1992–1999CrossRefPubMed Pancholy SB, Bernat I, Bertrand OF, Patel TM (2016) Prevention of radial artery occlusion after transradial catheterization: the PROPHET-II randomized trial. JACC Cardiovasc Interv 9:1992–1999CrossRefPubMed
13.
Zurück zum Zitat Pancholy S, Coppola J, Patel T, Roke-Thomas M (2008) Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv 72:335–340CrossRefPubMed Pancholy S, Coppola J, Patel T, Roke-Thomas M (2008) Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv 72:335–340CrossRefPubMed
14.
Zurück zum Zitat Pancholy SB, Bertrand OF, Patel T (2012) Comparison of a priori versus provisional heparin therapy on radial artery occlusion after transradial coronary angiography and patent hemostasis (from the PHARAOH Study). Am J Cardiol 110:173–176CrossRefPubMed Pancholy SB, Bertrand OF, Patel T (2012) Comparison of a priori versus provisional heparin therapy on radial artery occlusion after transradial coronary angiography and patent hemostasis (from the PHARAOH Study). Am J Cardiol 110:173–176CrossRefPubMed
15.
Zurück zum Zitat Patel AD, Ibrahim M, Swaminathan RV, Minhas IU, Kim LK, Venkatesh P, Feldman DN, Minutello RM, Bergman GW, Wong SC, Singh HS (2017) Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 89(4):E124–E132CrossRefPubMed Patel AD, Ibrahim M, Swaminathan RV, Minhas IU, Kim LK, Venkatesh P, Feldman DN, Minutello RM, Bergman GW, Wong SC, Singh HS (2017) Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 89(4):E124–E132CrossRefPubMed
16.
Zurück zum Zitat Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R, Investigators CR-KPCRC (2014) Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 114:555–561CrossRefPubMed Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R, Investigators CR-KPCRC (2014) Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 114:555–561CrossRefPubMed
17.
Zurück zum Zitat Kuno T, Hirano K, Imaeda S, Hashimoto K, Ryuzaki T, Saito T, Yamazaki H, Tabei R, Kodaira M, Numasawa Y (2018) A transradial approach of cardiac catheterization for patients on dialysis. J Invasive Cardiol 30(6):212–217PubMed Kuno T, Hirano K, Imaeda S, Hashimoto K, Ryuzaki T, Saito T, Yamazaki H, Tabei R, Kodaira M, Numasawa Y (2018) A transradial approach of cardiac catheterization for patients on dialysis. J Invasive Cardiol 30(6):212–217PubMed
18.
Zurück zum Zitat Natsuaki M, Furukawa Y, Morimoto T, Sakata R, Kimura T, Investigators CR-KPCRC (2012) Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 110:1568–1577CrossRefPubMed Natsuaki M, Furukawa Y, Morimoto T, Sakata R, Kimura T, Investigators CR-KPCRC (2012) Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 110:1568–1577CrossRefPubMed
19.
Zurück zum Zitat Valgimigli M, Campo G, Penzo C, Tebaldi M, Biscaglia S, Ferrari R, Investigators R (2014) Transradial coronary catheterization and intervention across the whole spectrum of Allen test results. J Am Coll Cardiol 63:1833–1841CrossRefPubMed Valgimigli M, Campo G, Penzo C, Tebaldi M, Biscaglia S, Ferrari R, Investigators R (2014) Transradial coronary catheterization and intervention across the whole spectrum of Allen test results. J Am Coll Cardiol 63:1833–1841CrossRefPubMed
20.
Zurück zum Zitat Anderson HV, Shaw RE, Brindis RG, McKay CR, Klein LW, Krone RJ, Ho KK, Rumsfeld JS, Smith SC Jr, Weintraub WS (2007) Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. Am J Cardiol 99:189–196CrossRefPubMed Anderson HV, Shaw RE, Brindis RG, McKay CR, Klein LW, Krone RJ, Ho KK, Rumsfeld JS, Smith SC Jr, Weintraub WS (2007) Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. Am J Cardiol 99:189–196CrossRefPubMed
21.
Zurück zum Zitat Numasawa Y, Kohsaka S, Ueda I, Miyata H, Sawano M, Kawamura A, Noma S, Suzuki M, Nakagawa S, Momiyama Y, Fukuda K (2017) Incidence and predictors of bleeding complications after percutaneous coronary intervention. J Cardiol 69:272–279CrossRefPubMed Numasawa Y, Kohsaka S, Ueda I, Miyata H, Sawano M, Kawamura A, Noma S, Suzuki M, Nakagawa S, Momiyama Y, Fukuda K (2017) Incidence and predictors of bleeding complications after percutaneous coronary intervention. J Cardiol 69:272–279CrossRefPubMed
22.
Zurück zum Zitat Abdelaal E, Brousseau-Provencher C, Montminy S, Plourde G, MacHaalany J, Bataille Y, Molin P, Dery JP, Barbeau G, Roy L, Larose E, De Larochelliere R, Nguyen CM, Proulx G, Costerousse O, Bertrand OF, Interventional Cardiologists at Quebec Heart-Lung Institute (2013) Risk score, causes, and clinical impact of failure of transradial approach for percutaneous coronary interventions. JACC Cardiovasc Interv 6:1129–1137CrossRefPubMed Abdelaal E, Brousseau-Provencher C, Montminy S, Plourde G, MacHaalany J, Bataille Y, Molin P, Dery JP, Barbeau G, Roy L, Larose E, De Larochelliere R, Nguyen CM, Proulx G, Costerousse O, Bertrand OF, Interventional Cardiologists at Quebec Heart-Lung Institute (2013) Risk score, causes, and clinical impact of failure of transradial approach for percutaneous coronary interventions. JACC Cardiovasc Interv 6:1129–1137CrossRefPubMed
23.
Zurück zum Zitat Vora AN, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Faries DE, Zettler ME, Fonarow GC, Baker BA, Stone GW, Wang TY (2016) Factors associated with initial prasugrel versus clopidogrel selection for patients with acute myocardial infarction undergoing percutaneous coronary intervention: insights from the treatment with ADP receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. J Am Heart Assoc 5(9):e003946CrossRefPubMedPubMedCentral Vora AN, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Faries DE, Zettler ME, Fonarow GC, Baker BA, Stone GW, Wang TY (2016) Factors associated with initial prasugrel versus clopidogrel selection for patients with acute myocardial infarction undergoing percutaneous coronary intervention: insights from the treatment with ADP receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study. J Am Heart Assoc 5(9):e003946CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou FS, Roe MT, Peterson ED, Marso SP, National Cardiovascular Data R (2009) Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2:222–229CrossRefPubMed Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou FS, Roe MT, Peterson ED, Marso SP, National Cardiovascular Data R (2009) Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2:222–229CrossRefPubMed
25.
Zurück zum Zitat Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747CrossRefPubMed Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H (2011) Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123:2736–2747CrossRefPubMed
26.
Zurück zum Zitat Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, Danchin N, Deanfield JE, Hemingway H, Fox KAA, Timmis AD, Gale CP (2017) beta-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J Am Coll Cardiol 69:2710–2720CrossRefPubMedPubMedCentral Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, Danchin N, Deanfield JE, Hemingway H, Fox KAA, Timmis AD, Gale CP (2017) beta-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction. J Am Coll Cardiol 69:2710–2720CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Otsuka M, Shiode N, Nakao Y, Ikegami Y, Kobayashi Y, Takeuchi A, Harima A, Higaki T, Oi K, Dai K, Kawase T, Nakama Y, Suenari K, Nishioka K, Sakai K, Shimatani Y, Masaoka Y, Inoue I (2018) Comparison of radial, brachial, and femoral accesses using hemostatic devices for percutaneous coronary intervention. Cardiovasc Interv Ther 33:62–69CrossRefPubMed Otsuka M, Shiode N, Nakao Y, Ikegami Y, Kobayashi Y, Takeuchi A, Harima A, Higaki T, Oi K, Dai K, Kawase T, Nakama Y, Suenari K, Nishioka K, Sakai K, Shimatani Y, Masaoka Y, Inoue I (2018) Comparison of radial, brachial, and femoral accesses using hemostatic devices for percutaneous coronary intervention. Cardiovasc Interv Ther 33:62–69CrossRefPubMed
28.
Zurück zum Zitat Patel MR, Jneid H, Derdeyn CP, Klein LW, Levine GN, Lookstein RA, White CJ, Yeghiazarians Y, Rosenfield K, American Heart Association D, Interventional Cardiac Catheterization Committee of the Council on Clinical Cardiology CoCR, Intervention CoPVDCoCS, Anesthesia, Stroke C (2010) Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation 122:1882–1893CrossRefPubMed Patel MR, Jneid H, Derdeyn CP, Klein LW, Levine GN, Lookstein RA, White CJ, Yeghiazarians Y, Rosenfield K, American Heart Association D, Interventional Cardiac Catheterization Committee of the Council on Clinical Cardiology CoCR, Intervention CoPVDCoCS, Anesthesia, Stroke C (2010) Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation 122:1882–1893CrossRefPubMed
29.
Zurück zum Zitat Beathard GA, Urbanes A, Litchfield T (2017) Changes in the profile of endovascular procedures performed in freestanding dialysis access centers over 15 years. Clin J Am Soc Nephrol 12:779–786CrossRefPubMedPubMedCentral Beathard GA, Urbanes A, Litchfield T (2017) Changes in the profile of endovascular procedures performed in freestanding dialysis access centers over 15 years. Clin J Am Soc Nephrol 12:779–786CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Khawaja AZ, Cassidy DB, Al Shakarchi J, McGrogan DG, Inston NG, Jones RG (2016) Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis. J Vasc Access 17:103–110CrossRefPubMed Khawaja AZ, Cassidy DB, Al Shakarchi J, McGrogan DG, Inston NG, Jones RG (2016) Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis. J Vasc Access 17:103–110CrossRefPubMed
31.
Zurück zum Zitat Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Kimura T (2012) Comparison of 3-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention. Cardiovasc Interv Ther 27:84–92CrossRefPubMed Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Kimura T (2012) Comparison of 3-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention. Cardiovasc Interv Ther 27:84–92CrossRefPubMed
32.
Zurück zum Zitat Wang S, Asif A (2013) Transradial approach for cardiovascular interventions and its implications for hemodialysis vascular access. Semin Dial 26:E20–E29CrossRefPubMed Wang S, Asif A (2013) Transradial approach for cardiovascular interventions and its implications for hemodialysis vascular access. Semin Dial 26:E20–E29CrossRefPubMed
33.
Zurück zum Zitat Wu CC, Jiang H, Cheng J, Zhao LF, Sheng KX, Chen JH (2015) The outcome of the proximal radial artery arteriovenous fistula. J Vasc Surg 61:802–808CrossRefPubMed Wu CC, Jiang H, Cheng J, Zhao LF, Sheng KX, Chen JH (2015) The outcome of the proximal radial artery arteriovenous fistula. J Vasc Surg 61:802–808CrossRefPubMed
34.
Zurück zum Zitat Buyukhatipoglu H, Tiryaki O, Tahta K, Usalan C (2007) Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection. Nephrology 12:25–32CrossRefPubMed Buyukhatipoglu H, Tiryaki O, Tahta K, Usalan C (2007) Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection. Nephrology 12:25–32CrossRefPubMed
35.
Zurück zum Zitat Chin CY, Matsumura M, Maehara A, Zhang W, Lee CT, Yamamoto MH, Song L, Parviz Y, Jhalani NB, Mohan S, Ratner LE, Cohen DJ, Ben-Yehuda O, Stone GW, Shlofmitz RA, Kakuta T, Mintz GS, Ali ZA (2017) Coronary plaque characteristics in hemodialysis-dependent patients as assessed by optical coherence tomography. Am J Cardiol 119:1313–1319CrossRefPubMed Chin CY, Matsumura M, Maehara A, Zhang W, Lee CT, Yamamoto MH, Song L, Parviz Y, Jhalani NB, Mohan S, Ratner LE, Cohen DJ, Ben-Yehuda O, Stone GW, Shlofmitz RA, Kakuta T, Mintz GS, Ali ZA (2017) Coronary plaque characteristics in hemodialysis-dependent patients as assessed by optical coherence tomography. Am J Cardiol 119:1313–1319CrossRefPubMed
36.
Zurück zum Zitat Mamas MA, Fraser DG, Ratib K, Fath-Ordoubadi F, El-Omar M, Nolan J, Neyses L (2014) Minimising radial injury: prevention is better than cure. EuroIntervention 10:824–832CrossRefPubMed Mamas MA, Fraser DG, Ratib K, Fath-Ordoubadi F, El-Omar M, Nolan J, Neyses L (2014) Minimising radial injury: prevention is better than cure. EuroIntervention 10:824–832CrossRefPubMed
37.
Zurück zum Zitat Itaya H, Nakamura M (2012) Novel strategy for percutaneous transluminal angioplasty for complex critical hand. Cardiovasc Interv Ther 27:52–56CrossRefPubMed Itaya H, Nakamura M (2012) Novel strategy for percutaneous transluminal angioplasty for complex critical hand. Cardiovasc Interv Ther 27:52–56CrossRefPubMed
38.
Zurück zum Zitat Corcos T (2019) Distal radial access for coronary angiography and percutaneous coronary intervention: a state-of-the-art review. Catheter Cardiovasc Interv 93:639–644CrossRefPubMed Corcos T (2019) Distal radial access for coronary angiography and percutaneous coronary intervention: a state-of-the-art review. Catheter Cardiovasc Interv 93:639–644CrossRefPubMed
39.
Zurück zum Zitat Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L, Revascularisation Fast, Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators (2006) 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368:998–1004CrossRefPubMed Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L, Revascularisation Fast, Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators (2006) 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368:998–1004CrossRefPubMed
40.
Zurück zum Zitat Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Group TS (2004) Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J 25:1998–2005CrossRefPubMed Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Group TS (2004) Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J 25:1998–2005CrossRefPubMed
Metadaten
Titel
Trans-radial percutaneous coronary intervention for patients with severe chronic renal insufficiency and/or on dialysis
verfasst von
Toshiki Kuno
Keita Hirano
Takayuki Abe
Shohei Imaeda
Kenji Hashimoto
Toshinobu Ryuzaki
Souichi Yokokura
Tetsuya Saito
Hiroyuki Yamazaki
Ryota Tabei
Masaki Kodaira
Yohei Numasawa
Publikationsdatum
22.03.2019
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 9/2019
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01387-0

Weitere Artikel der Ausgabe 9/2019

Heart and Vessels 9/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.